These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 3972233
1. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome. McArthur KE, Collen MJ, Maton PN, Cherner JA, Howard JM, Ciarleglio CA, Cornelius MJ, Jensen RT, Gardner JD. Gastroenterology; 1985 Apr; 88(4):939-44. PubMed ID: 3972233 [Abstract] [Full Text] [Related]
5. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Clissold SP, Campoli-Richards DM. Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658 [Abstract] [Full Text] [Related]
6. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists. Delchier JC, Soule JC, Mignon M, Goldfain D, Cortot A, Travers B, Isal JP, Bader JP. Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001 [Abstract] [Full Text] [Related]
7. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. Lambers CB, Lind T, Moberg S, Jansen JB, Olbe L. N Engl J Med; 1984 Mar 22; 310(12):758-61. PubMed ID: 6142418 [Abstract] [Full Text] [Related]
8. Efficacy of long-term therapy with low doses of omeprazole in the control of gastric acid secretion in Zollinger-Ellison syndrome patients. Corleto V, Annibale B, D'Ambra G, Saggioro A, Ferrua B, Cassetta MR, Delle Fave G. Aliment Pharmacol Ther; 1993 Apr 22; 7(2):167-73. PubMed ID: 8485270 [Abstract] [Full Text] [Related]
10. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h. Hirschowitz BI, Mohnen J, Shaw S. Aliment Pharmacol Ther; 1996 Aug 22; 10(4):497-506. PubMed ID: 8853753 [Abstract] [Full Text] [Related]
12. Role of acid suppressants in patients with Zollinger-Ellison syndrome. Maton PN. Aliment Pharmacol Ther; 1991 Aug 22; 5 Suppl 1():25-35. PubMed ID: 1679671 [Abstract] [Full Text] [Related]
13. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study. Hirschowitz BI, Simmons J, Mohnen J. Aliment Pharmacol Ther; 2001 Nov 22; 15(11):1795-806. PubMed ID: 11683694 [Abstract] [Full Text] [Related]
16. Treatment of patients with Zollinger-Ellison syndrome. Mignon M, Pospai D, Forestier S, Vatier J, Vallot T. Clin Ther; 1993 Nov 22; 15 Suppl B():22-31. PubMed ID: 8205592 [Abstract] [Full Text] [Related]
17. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers. Meijer JL, Jansen JB, Lamers CB. Digestion; 1989 Nov 22; 44 Suppl 1():31-9. PubMed ID: 2575060 [Abstract] [Full Text] [Related]
18. Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. Metz DC, Soffer E, Forsmark CE, Cryer B, Chey W, Bochenek W, Pisegna JR. Am J Gastroenterol; 2003 Feb 22; 98(2):301-7. PubMed ID: 12591045 [Abstract] [Full Text] [Related]
19. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety. Metz DC, Strader DB, Orbuch M, Koviack PD, Feigenbaum KM, Jensen RT. Aliment Pharmacol Ther; 1993 Dec 22; 7(6):597-610. PubMed ID: 8161665 [Abstract] [Full Text] [Related]